Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Neurocrit Care. 2012 Feb;16(1):82–87. doi: 10.1007/s12028-011-9619-3

Table 1.

Demographics

Variable N (%), mean ± SD, or median [Q1–Q3]
Ethnicity, Caucasian 25 (56)
African American 14 (31)
Hispanic 3 (7)
East Asian/Oceania 2 (4)
Native American 1 (2)
Women 19 (42)
Age, years 67.3 ± 14.0
Aspirin use, 81 mg daily 16 (35)
More than 81 mg daily 6 (13)
Clopidogrel use 10 (22)
Warfarin with INR 32 3 (3)
ICH volume on admission, ml 14 [7–31]
Hours from symptom onset to first CT 4 [1–12]